Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ping An International Smart City Technology is a Shenzhen-based Ping An Group subsidiary focused primarily on smart-city technology, digital government, and enterprise software, with a healthcare-related business line in medical artificial intelligence. The company has developed AI-enabled healthcare tools including retinal screening systems based on optical coherence tomography and fundus imaging, and has collaborated with the University of Hong Kong on clinical validation of these systems. Beyond healthcare, it provides smart-city planning, cloud, AI, blockchain, and digital platform solutions for municipalities and enterprises. It appears to be an operating technology company rather than a therapeutics developer, so it does not have a traditional biotech or pharma drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ping An International Smart City Technology.